CR Group L.P.
T2 Biosystems, Inc. · 10% Owner
CR Group L.P. holds a significant position as a 10% owner of T2 Biosystems, Inc. This profile details their insider activity through SEC Form 4 filings, reflecting a total of 19 public disclosures from February 16, 2024, to May 13, 2024. All disclosed transactions are related to T2 Biosystems, Inc. (TTOO), highlighting their exclusive focus on the healthcare sector.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||